Get started
Author

Konstantinos Zervas

Observed names: K Zervas, K. Zervas, Zervas K, Zervas Konstantinos, Zervas, K
Observed institutions: University of Patras, Pfizer (United States), National and Kapodistrian University of Athens, Aristotle University of Thessaloniki, Sismanoglio General Hospital, AHEPA University Hospital, Hellenic Air Force, Theageneio General Hospital, Institut de Virologie, Laboratoire des Sciences de l'Ingénieur, de l'Informatique et de l'Imagerie, Hellenic Airforce General Hospital, General Hospital of Athens G. Genimatas, NIHR Academy, Metaxa Hospital, G. Papanikolaou General Hospital, Evangelismos Hospital, All India Institute of Medical Sciences Rishikesh, Institute for Translational Medicine and Liver Disease, British Gynaecological Cancer Society, European Society of Coloproctology, University of Birmingham
ORCID: 0000-0003-3670-7908
Observed ORCID: 0000-0003-3670-7908
OpenAlex ID: A5029337337
Longitudinal Cohort Study of Risk Factors in Cancer Patients of Bisphosphonate-Related Osteonecrosis of the Jaw
2009 · Konstantinos Vahtsevanos, Athanassios Kyrgidis, et al. · Journal of Clinical Oncology · 463
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
2021 · James Glasbey, Adesoji Ademuyiwa, et al. · The Lancet Oncology · 289
Thalidomide and dexamethasone combination for refractory multiple myeloma
2001 · M.A. Dimopoulos, K. Zervas, et al. · Annals of Oncology · 281
PDF
Primary Treatment of Waldenström Macroglobulinemia With Dexamethasone, Rituximab, and Cyclophosphamide
2007 · Meletios Athanasios Dimopoulos, Athanasios Anagnostopoulos, et al. · Journal of Clinical Oncology · 279
PDF
Renal failure in multiple myeloma: Incidence, correlations, and prognostic significance
2007 · V. Eleutherakis-Papaiakovou, A. Bamias, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 231
Elective Cancer Surgery in COVID-19–Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study
2020 · James C. Glasbey, Dmitri Nepogodiev, et al. · Journal of Clinical Oncology · 223
Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG)
2009 · E Kastritis, K Zervas, et al. · Leukemia · 187
Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: Reduction post‐bortezomib monotherapy
2011 · Evangelos Terpos, Dimitrios Christoulas, et al. · International Journal of Cancer · 184
High serum lactate dehydrogenase adds prognostic value to the international myeloma staging system even in the era of novel agents
2010 · Evangelos Terpos, Eirini Katodritou, et al. · European Journal Of Haematology · 145
Delaying surgery for patients with a previous SARS-CoV-2 infection
2020 · COVIDSurg Collaborative, James C Glasbey, et al. · British journal of surgery · 139
Primary treatment of multiple myeloma with thalidomide, vincristine, liposomal doxorubicin and dexamethasone(T-VAD doxil): a phase II multicenter study
2003 · K. Zervas, M.A. Dimopoulos, et al. · Annals of Oncology · 119
The combination of intermediate doses of thalidomide with dexamethasone is an effective treatment for patients with refractory/relapsed multiple myeloma and normalizes abnormal bone remodeling, through the reduction of sRANKL/osteoprotegerin ratio
2005 · E Terpos, D Mihou, et al. · Leukemia · 103
Prospective randomized comparison of vincristine, doxorubicin and dexamethasone (VAD) administered as intravenous bolus injection and VAD with liposomal doxorubicin as first-line treatment in multiple myeloma
2003 · M.A. Dimopoulos, A. Pouli, et al. · Annals of Oncology · 77
PDF
Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: A report of the Greek myeloma study group in 97 patients
2014 · Eirini Katodritou, Evangelos Terpos, et al. · American Journal of Hematology · 70
PDF
Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration
2009 · E. Terpos, E. Katodritou, et al. · Haematologica · 70
PDF
Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic
2020 · COVIDSurg Collaborative, James C Glasbey, et al. · British journal of surgery · 66
PDF
VAD-doxil versus VAD-doxil plus thalidomide as initial treatment for multiple myeloma: results of a multicenter randomized trial of the Greek myeloma study group
2007 · K Zervas, D Mihou, et al. · Annals of Oncology · 66
PDF
Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's macroglobulinemia (WM) and the importance of serum lactate dehydrogenase (LDH)
2010 · Efstathios Kastritis, Marie-Christine Kyrtsonis, et al. · Leukemia Research · 62
Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study
2022 · Christina Fotopoulou, Tabassum Khan, et al. · American Journal of Obstetrics and Gynecology · 60
PDF
Multiple myeloma in elderly patients: prognostic factors and outcome
2005 · Athanasios Anagnostopoulos, Dimitra Gika, et al. · European Journal Of Haematology · 59
Survival and prognostic factors after initiation of treatment in Waldenstrom’s macroglobulinemia
2003 · M.A. Dimopoulos, G. Hamilos, et al. · Annals of Oncology · 52
Primary treatment with pulsed melphalan, dexamethasone and thalidomide for elderly symptomatic patients with multiple myeloma.
2006 · Meletios A Dimopoulos, Athanasios Anagnostopoulos, et al. · PubMed · 46
The combination of lenalidomide and dexamethasone reduces bone resorption in responding patients with relapsed/refractory multiple myeloma but has no effect on bone formation: Final results on 205 patients of the Greek myeloma study group
2013 · Evangelos Terpos, Dimitrios Christoulas, et al. · American Journal of Hematology · 41
PDF
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic
2021 · STARSurg Collaborative and COVIDSurg Collaborative, K A McLean, et al. · British journal of surgery · 40
PDF
No significant improvement in the outcome of patients with Waldenström's macroglobulinemia treated over the last 25 years
2011 · Efstathios Kastritis, Marie‐Christine Kyrtsonis, et al. · American Journal of Hematology · 40
PDF
Works count: 100
Citation count: 4,087
H-index: 31
I10-index: 51
Year
Topic
Type